Cyanosis is a bluish discoloration of the skin and mucous membranes caused by low oxygen levels. It can be due to pulmonary or cardiac issues. Pulmonary causes include problems leading to ventilation-perfusion mismatching or low oxygen exchange in the lungs. Cardiac causes are congenital heart defects causing right-to-left shunts, reducing oxygenated blood to the body. Diagnosis involves physical exam, blood tests, chest x-ray, and oxygen responsiveness testing to distinguish between cardiac and pulmonary etiologies. Initial management focuses on stabilization, monitoring, supportive care like oxygen, and treating any underlying issues like sepsis.
a not-for profit/sale presentation for educational purposes only.
Design heavily influenced and inspired by Jesse Desjardins. Thank you to Jesse Desjardins.
Single ventricle presentation for pediatricianLaxmi Ghimire
As the number of children who survive single ventricle physiology, it is very important for the pediatrician to understand about them to give them the best care.
Cardiomyopathy (KAR-de-o-mi-OP-ah-thee) refers to diseases of the heart muscle. These diseases have many causes, signs and symptoms, and treatments.
In cardiomyopathy, the heart muscle becomes enlarged, thick, or rigid. In rare cases, the muscle tissue in the heart is replaced with scar tissue.
As cardiomyopathy worsens, the heart becomes weaker. It's less able to pump blood through the body and maintain a normal electrical rhythm. This can lead toheart failure or irregular heartbeats called arrhythmias (ah-RITH-me-ahs). In turn, heart failure can cause fluid to build up in the lungs, ankles, feet, legs, or abdomen.
The weakening of the heart also can cause other complications, such as heart valve problems.
OverviewThe main types of cardiomyopathy are:
Dilated cardiomyopathy
Hypertrophic (hi-per-TROF-ik) cardiomyopathy
Restrictive cardiomyopathy
Arrhythmogenic (ah-rith-mo-JEN-ik) right ventricular dysplasia
(dis-PLA-ze-ah)
Other types of cardiomyopathy sometimes are referred to as "unclassified cardiomyopathy."
Cardiomyopathy can be acquired or inherited. "Acquired" means you aren't born with the disease, but you develop it due to another disease, condition, or factor. "Inherited" means your parents passed the gene for the disease on to you. Many times, the cause of cardiomyopathy isn't known.
Cardiomyopathy can affect people of all ages. However, people in certain age groups are more likely to have certain types of cardiomyopathy. This article focuses on cardiomyopathy in adults.
OutlookSome people who have cardiomyopathy have no signs or symptoms and need no treatment. For other people, the disease develops quickly, symptoms are severe, and serious complications occur.
Treatments for cardiomyopathy include lifestyle changes, medicines, surgery, implanted devices to correct arrhythmias, and a nonsurgical procedure. These treatments can control symptoms, reduce complications, and stop the disease from getting worse.
National Heart Lung and Blood Institute
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
3. Introduction
Cyanosis is the bluish discoloration of the skin and
mucous membranes due to increased concentration of
reduced hemoglobin to about >5g/100 mL in the
cutaneous veins
Desaturation of arterial blood
Increased extraction of oxygen by peripheral tissue in
the presence of normal arterial saturation
Detected –lips,fingernails,oral mucous
membranes,conjuctiva and tip of tongue
4. Factors affecting detection of
cyanosis in newborn
Hemoglobin concentration
Fetal hemoglobin
Skin pigmentation
5. Hemoglobin
concentration
The arterial oxygen saturation level at which cyanosis is detectable at
different total hemoglobin concentrations is illustrated above. The
solid red portion of each bar represents 3 gm/dL reduced hemoglobin.
6. Fetal hemoglobin
The oxygen-dissociation curve of human blood and the effects of
changes in the H+ ion concentration, Pco2 temperature and level of
2, 3-diposphoglycerate (2,3-DPG) are depicted above. For fetal
hemoglobin, the normal curve (a) is shifted to the left (b).
7. Skin pigmentation
Less apparent in the skin of babies with darker
pigmentation.
Examination should include the nail beds, tongue,
and mucous membranes, which are less affected by
pigmentation.
13. Cardiac causes- "five Ts" of cyanotic CHD:
Transposition of the great arteries
Tetralogy of Fallot
Truncus arteriosus
Total anomalous pulmonary venous connection
Tricuspid valve abnormalities.
A sixth "T" is often added for "tons" of other diseases,
such as double outlet right ventricle, pulmonary atresia,
multiple variations of single ventricle, hypoplastic left
heart syndrome, or anomalous systemic venous
connection (left superior vena cava connected to the
left atrium).
14. Hemoglobinopathies
Hereditary < exposure to toxic substances
>15%- cyanosis
>70% -lethal
Remain chocolate brown-even with full oxygenation or
long exposure to room air
15. Central cyanosis
Inadequate alveolar
ventilation
CNS depression
Inadequate ventilatory drive
Obstruction
Structural changes
Muscle weakness
Desaturated blood
bypassing alveolar units
Intracardiac R-L
Intrapulmonary shunt
Pulmonary hypertension
with R-L shunt
16. Peripheral cyanosis
Peripheral cyanosis, involves a bluish discoloration of the
skin but sparing of the mucus membranes & tongue. In this
type, a normal PaO2 value is detected
Increased oxygen extraction due to sluggish movement
through the capillaries leads to increased deoxygenated
blood on the venous side
Vasomotor instability,vasoconstriction caused by cold, low
cardiac output, venous obstruction, elevated venous
pressure and polycythemia
17.
18. Acrocyanosis
Bluish discoloration of fingers seen in neonates and infants
due to vasoconstriction as a result of transient hypothermia
No clinical significance unless associated with circulatory
shock
Circum-oral cyanosis
Healthy child with fair skin due to sluggish blood flow
with vasoconstriction
No clinical significance unless associated with low
cardiac output
19. Cardiac vs Pulmonary
Hyperoxiatest-
Response of arterial PaO2 to 100%oxygen inhalation
Result in PaO2 Disease
>100mm Hg Lung disease
Large pulmonary blood flow
(TAPVR)
<100mm Hg Massive intra-pulmonary shunt
with normal heart
<10-30mm Hg increase
(<100)
Intra-cardiac right to left shunt
22. Antenatal history
Fetal ultrasound scans- congenital heart disease,
diaphragmatic hernia and congenital cystic
adenomatoid malformation (CCAM).
Family history of CHD
23.
24. Physical examination
Vitals
R/o choanal atresia
Respiratory system
Cardiovascular system
Abdomen
Neurological disorders
25. Vitals
Vital signs-
signs of respiratory distress such as tachypnea,
retractions, nasal flaring & grunting usually indicate a
respiratory problem
congenital heart disease is often accompanied by absent
or effortless tachypnea.
Sepsis often has the following findings: peripheral
cyanosis, HR, RR, BP, / temp
26. R/o choanal atresia
Cyanosis decreases during crying
Confirmed by failure to pass a soft No. 5F to 8F
catheter through each nostril
27. Respiratory system
Inspiratory stridor-
upper airway obstruction
Chest-
Asymmetric chest movement combined with severe
distress-
alarming sign for tension pneumothorax, diaphragmatic
hernia
Transillumination of the chest-
Pneumothorax
28. Cardiovascular system
A systolic murmur audible in most forms of cyanotic
CHD (exception: d-TGA with intact ventricular septum &
no pulmonary stenosis).
Respirations often are unlabored unless there is
pulmonary congestion or complicated by the
development of heart failure or acidosis, which will
affect the respiratory pattern
30. Neurological disorders
Observe for apnea and periodic breathing, which may
be related to immaturity of the nervous system.
Seizures can cause cyanosis if the infant fails to
breathe during the episodes.
32. CBC & diff :
or WBC sepsis
hematocrit > 65% polycythemia
Serum glucose: to detect hypoglycemia
Arterial Blood Gases (ABGs):
Arterial PO2: to confirm central cyanosis SaO2 not as good an indicator
due to fetal Hb affinity for O2 (left-shift)
PaCO2: may indicate pulmonary or CNS disorders, heart failure
pH: sepsis, circulatory shock, severe hypoxemia
Methemoglobinemia: SaO2, normal PaO2, chocolate-brown blood
33. X-ray -Increased pulmonary
vascularity
RVH on ECG
D-TGA
TAPVR with obstruction
DORV with subpulmonary VSD
PPHN
LVH/BVH on ECG
Persistent truncus arteriosus
Single ventricle
TGA and VSD
Polysplenia syndrome
34. X-ray -Decreased pulmonary
vascularity
RVH on ECG
TOF
DORV with PS
Asplenia syndrome
RBBB on ECG
Ebstein’s anomaly
LVH on ECG
Pulmonary atresia
Tricuspid atresia
BVH on ECG
TGA and PS
Persistent truncus arteriosus
Single ventricle and PS
38. Arterial PaO2 in preductal and
postductal arteries
Right upper body-radial,brachial,temporal
Umbilical artery line
PaO2 should be compared
Right radial-umbilical artery=>10-15 mm Hg
39. Differential cyanosis
In severe R-L ductal shunt
Pink-upper and cyanosed-lower
Causes
PPHN
Severe AS
Interrupted aortic arch
Coarctation of aorta
40. Initial management
Monitor Airway, breathing, circulation (ABCs)
with respiratory compromise, establish an airway &
provide supportive therapy (e.g., oxygen, mechanical
ventilation)
Monitor Vital signs
Establish vascular access for sampling blood &
administering medicatons(if needed)
umbilical vessels convenient for placement of intravenous
& intra-arterial catheters
41. If sepsis is suspected or another specific cause is not
identified, start on broad spectrum antibiotics (e.g.,
ampicillin and gentamycin) after obtaining a CBC,
urinalysis, blood & urine cultures (if possible). Left
untreated, sepsis may lead to pulmonary disease & left
ventricular dysfunction.
Secure a separate intravenous catheter to provide
fluids for resuscitation and ensure accessibility of
intubation equipment should they be required.
42. Prostaglandin E1 infusion
Prostaglandin E1
For cyanotic CHD/duct dependent cardiac defect
Infusion of prostaglandin E1 at a dose of 0.05-
0.1mcg/kg/min intravenously
Increase PaO2,increase systemic blood
pressure,improved pH-tapered 0.01mcg/kg/min
No effect-increased upto 0.4mcg/kg/min
Side effects-apnea(12%),fever(14%),flushing(10%)
Less common side effects-
tachy/bradycardia,hypotension,cardiac arrest
44. System Causes Clinical findings
CNS depression Perinatal asphyxia
Heavy maternal sedation
Intra uterine fetal distress
• Shallow irregular respiration
• Poor muscle tone
• Cyanosis disappears when
patient is stimulated or O2
given
Pulmonary disease Parenchyma
Pneumothorax or pleural
effusion
Diaphragmatic hernia
PPHN
• Tachypnea, respiratory
distress with retraction and
expiratory grunt
• Crackles or decreased
breath sounds
• X-ray findings
• Improve/abolish with oxygen
inhalation
Cardiac disease Cyanotic CHD with R-L shunt • Tachypnea without
retractions
• lack of crackles/abnormal
breath sounds
• Continuous murmur(PDA)
• X-ray findings
• Little/no increase with O2
45. Conclusion
Central cyanosis in a newborn is an abnormal finding and
one must consider all of the possible etiologies with a
complete history, physical examination and relevant
investigations.
Remember to think about the various mechanisms causing
cyanosis and go through each systematically until you have
your diagnosis.
Prompt management should be undertaken while you are
trying to figure out your diagnosis.
For ductal dependent lesion, start prostaglandin E1 and
early referral